Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armin Koch

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Biometrical Journal. Biometrische Zeitschrift|September 16, 2006
Confirmatory clinical trials with an adaptive designArmin Koch
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|May 3, 2011
[Benefits and harms - two sides of the same medal?]Armin Koch
Contemporary Clinical Trials|April 20, 2005
How much do we have to pay for how many interim analyses?Armin Koch
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 8, 2010
The risk of death among adult participants in trials of antipsychotic drugs in schizophreniaMaria Isaac, Armin Koch
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 10, 2017
[Ethical aspects of clinical trials in rare diseases]Joerg Hasford, Armin Koch
Journal of Biopharmaceutical Statistics|June 23, 2004
Hypothesis testing in the "gold standard" design for proving the efficacy of an experimental treatment relative to placebo and a referenceArmin Koch, Joachim Röhmel
Pharmaceutical Statistics|March 23, 2019
Commentary on: Subgroup analysis and interpretation for phase 3 confirmatory trials: White Paper of the EFSPI/PSI working group on subgroup analysis by Dane, Spencer, Rosenkranz, Lipkovich, and ParkeRobert Hemmings, Armin Koch
Journal of Biopharmaceutical Statistics|January 8, 2014
Reliably basing conclusions on subgroups of randomized clinical trialsArmin Koch, Theodor Framke
Biometrical Journal. Biometrische Zeitschrift|July 4, 2015
Does it help that efficacy has been proven once we start discussing (added) benefit?Armin Koch, Yvonne Ziert
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|July 19, 2017
Erratum to: Ethical aspects of clinical trials in rare diseasesJoerg Hasford, Armin Koch
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Biometrical Journal. Biometrische Zeitschrift|September 16, 2006
Confirmatory clinical trials with an adaptive designArmin Koch
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|May 3, 2011
[Benefits and harms - two sides of the same medal?]Armin Koch
Contemporary Clinical Trials|April 20, 2005
How much do we have to pay for how many interim analyses?Armin Koch
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 8, 2010
The risk of death among adult participants in trials of antipsychotic drugs in schizophreniaMaria Isaac, Armin Koch
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 10, 2017
[Ethical aspects of clinical trials in rare diseases]Joerg Hasford, Armin Koch
Journal of Biopharmaceutical Statistics|June 23, 2004
Hypothesis testing in the "gold standard" design for proving the efficacy of an experimental treatment relative to placebo and a referenceArmin Koch, Joachim Röhmel
Pharmaceutical Statistics|March 23, 2019
Commentary on: Subgroup analysis and interpretation for phase 3 confirmatory trials: White Paper of the EFSPI/PSI working group on subgroup analysis by Dane, Spencer, Rosenkranz, Lipkovich, and ParkeRobert Hemmings, Armin Koch
Journal of Biopharmaceutical Statistics|January 8, 2014
Reliably basing conclusions on subgroups of randomized clinical trialsArmin Koch, Theodor Framke
Biometrical Journal. Biometrische Zeitschrift|July 4, 2015
Does it help that efficacy has been proven once we start discussing (added) benefit?Armin Koch, Yvonne Ziert
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|July 19, 2017
Erratum to: Ethical aspects of clinical trials in rare diseasesJoerg Hasford, Armin Koch
Pageof 11